Pura Vida Investments’s ResMed RMD Stock Holding History

Pura Vida Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,000	Closed	-$3.27M	–	237
2022 Q3	$3.27M	Buy	+15,000	New	+$3.41M	0.19%	111
2015 Q1	–	Sell	-142,900	Closed	-$8.01M	–	80
2014 Q4	$8.01M	Buy	+142,900	New	+$7.46M	2.95%	5

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Pura Vida Investments's RMD Position: Q4 2022 in Review

Pura Vida Investments sold out of ResMed (RMD) in Q4 2022, closing a stake of 15,000 shares — an estimated $3.27M sold.

Pura Vida Investments first reported a position in RMD in Q4 2014 and held it in 2 quarters. The position peaked at $8.01M in Q4 2014. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Pura Vida Investments reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 15,000 ResMed shares in Q4 2022, an estimated $3.27M.
Pura Vida Investments first reported a position in ResMed in Q4 2014 and held it in 2 quarters.
Pura Vida Investments's ResMed position peaked at $8.01M in Q4 2014.
731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.